Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
ANAHEIM, Calif., Jan. 8, 2014
ANAHEIM, Calif., Jan. 8, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.
(NASDAQ: QCOR) announced today that Don Bailey, the Company's President and
Chief Executive Officer, will present at the J.P. Morgan Healthcare Conference
in San Francisco on January 16, 2014 at 9:00 AM PT/12:00 PM ET.
A live webcast and subsequent archived replay of the presentation will be
accessible at http://ir.questcor.com/events.cfm. The replay will be available
for approximately 90 days after the event.
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
treatment of patients with serious, difficult-to-treat autoimmune and
inflammatory disorders. Questcor also provides specialty contract
manufacturing services to the global pharmaceutical industry through its
wholly-owned subsidiary BioVectra Inc. For more information about Questcor,
please visit www.questcor.com.
SOURCE Questcor Pharmaceuticals, Inc.
Contact: EVC Group, Gregory Gin/Patty Eisenhaur, 646-445-4801/951-316-0577,
Janine McCargo, 646-688-0425
Press spacebar to pause and continue. Press esc to stop.